Allison Creekmore

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

X. Cynthia, Matthew J. Ellis, Gina R. Petroni et al. · Breast Cancer Research and Treatment · 2012 · 107 citations · Full text

Breast Oncology, Checkpoint Kinase 1, Medicine +14

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

X. Cynthia, César Sánchez, Feng Gao et al. · Clinical Cancer Research · 2016 · 76 citations · Full text

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

Paula M. Fracasso, Kerry J. Williams, Ronald C. Chen et al. · Cancer Chemotherapy and Pharmacology · 2010 · 68 citations · Full text

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

Paula M. Fracasso, Joel Picus, Jonathan D. Wildi et al. · Cancer Chemotherapy and Pharmacology · 2008 · 49 citations

Oncology, Health Sciences, Weekly Docosahexaenoic Acid-paclitaxel +11

Coaching Intervention As a Strategy for Minority Recruitment to Cancer Clinical Trials

Paula M. Fracasso, Sherry A. Goodner, Allison Creekmore et al. · Journal of Oncology Practice · 2013 · 29 citations · Full text